ENTPD5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.24879999996441E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.238490E-04 |
Normal-vs-Stage2 |
7.98330000000291E-05 |
Normal-vs-Stage3 |
1.1715999947981E-08 |
Normal-vs-Stage4 |
4.38170000000015E-05 |
Stage1-vs-Stage2 |
1.619840E-01 |
Stage1-vs-Stage3 |
1.97190999999819E-05 |
Stage1-vs-Stage4 |
8.415900E-02 |
Stage2-vs-Stage3 |
3.068600E-01 |
Stage2-vs-Stage4 |
5.951200E-01 |
Stage3-vs-Stage4 |
8.477000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.15439999995404E-06 |
Normal-vs-AfricanAmerican |
6.16370000039446E-07 |
Normal-vs-Asian |
1.877920E-03 |
Caucasian-vs-AfricanAmerican |
1.852810E-01 |
Caucasian-vs-Asian |
8.085000E-01 |
AfricanAmerican-vs-Asian |
8.294600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.59390000087356E-08 |
Normal-vs-Female |
7.242500E-03 |
Male-vs-Female |
3.57240000000703E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.6888499999923E-05 |
Normal-vs-Age(41-60Yrs) |
2.34659999998055E-06 |
Normal-vs-Age(61-80Yrs) |
5.1785999999332E-07 |
Normal-vs-Age(81-100Yrs) |
2.519800E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.814360E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.097200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.324800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.749200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.454000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.413000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.289000E-01 |
Normal-vs-Grade 2 |
3.64339999999741E-05 |
Normal-vs-Grade 3 |
1.74056999999728E-05 |
Normal-vs-Grade 4 |
8.30924218320206E-12 |
Grade 1-vs-Grade 2 |
4.939800E-01 |
Grade 1-vs-Grade 3 |
5.281200E-01 |
Grade 1-vs-Grade 4 |
7.063900E-03 |
Grade 2-vs-Grade 3 |
6.364600E-01 |
Grade 2-vs-Grade 4 |
2.79454237528398E-12 |
Grade 3-vs-Grade 4 |
6.38299999966563E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.919100E-03 |
Normal-vs-ccB subtype |
4.72910000048898E-09 |
ccA subtype-vs-ccB subtype |
4.87869966647736E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.66802999999049E-05 |
Normal-vs-N1 |
2.35719999075457E-09 |
N0-vs-N1 |
4.171000E-04 |
|
|